High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$5.0M
$4,951,402
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-03-04 | $797,351x8 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-03-02 | $722,801x10 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-02-13 | $695,201 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Poulton Jeffrey V.
• CFO
Sell to Cover
2026-01-12
$1,008,766Largex21
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-01-12 | $1,008,766Largex21 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Poulton Jeffrey V.
• CFO
Sell to Cover
2025-10-02
$1,727,284Largex12
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2025-10-02 | $1,727,284Largex12 | S | Form 4 |